What was the outcome of Abelardo Aguilar's attempt to seek royalties for the discovery of the antibiotic erythromycin?
Answer
His efforts to claim compensation were unsuccessful.
Despite his pivotal role in identifying and collecting the soil sample containing Streptomyces erythreus, Abelardo Aguilar did not receive financial recognition or royalties for the discovery. Eli Lilly and Company owned the patent and the manufacturing process, and Aguilar's legal and personal attempts to secure compensation for his contribution were ultimately unsuccessful.
Related Questions
Who is credited with isolating the strain of bacteria that led to the development of erythromycin?Which pharmaceutical company was responsible for filing the patent for the antibiotic derived from the soil sample collected by Abelardo Aguilar?In which specific location were the soil samples collected that contained the bacteria Streptomyces erythreus?What is the primary biological mechanism by which erythromycin stops the growth of bacteria?To which class of antibiotics does erythromycin belong?For what clinical reason was erythromycin primarily developed as an alternative treatment to penicillin?What was the outcome of Abelardo Aguilar's attempt to seek royalties for the discovery of the antibiotic erythromycin?What is the scientific name of the bacterium that was discovered in the soil samples sent by Abelardo Aguilar?Unlike macrolides such as erythromycin, what is the primary mechanism of action for fluoroquinolones?What was the primary role of Eli Lilly and Company in the development of erythromycin?